EP2427216

USES OF IMMUNOCONJUGATES TARGETING CD138

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    5.5.2010
  • EP published:
    20.2.2019
  • EP application number:
    10718581.1
  • Max expiry date:
    4.5.2030
  • Title:
    USES OF IMMUNOCONJUGATES TARGETING CD138

Timeline

Today
5.5.2010EP application
20.2.2019EP Publication

Owner

  • Name:
    Biotest AG
  • Address:
    Landsteinerstr. 5, 63303, Dreieich, DE
  • Name:
    ImmunoGen, Inc.
  • Address:
    830 Winter Street, 02451, Waltham, MA, US

Inventor

  • Name:
    OSTERROTH, Frank
  • Address:
    Dietzenbach, DE
  • Name:
    UHEREK, Christoph
  • Address:
    Seligenstadt, DE
  • Name:
    BRUECHER, Christoph
  • Address:
    Eschborn, DE
  • Name:
    DAELKEN, Benjamin
  • Address:
    Frankfurt am Main, DE
  • Name:
    ENGLING, André
  • Address:
    Frankfurt, DE
  • Name:
    HAEDER, Thomas
  • Address:
    Dreieich, DE
  • Name:
    WARTENBERG-DEMAND, Andrea
  • Address:
    Schecksbach, DE
  • Name:
    NIEMANN, Gabriele
  • Address:
    Walzbachtal, DE
  • Name:
    ZUBER, Chantal
  • Address:
    Frankfurt, DE
  • Name:
    CZELOTH, Niklas
  • Address:
    Dreieich, DE
  • Name:
    AIGNER, Silke
  • Address:
    Frankenthal, DE
  • Name:
    ZENG, Steffen
  • Address:
    Münster, DE
  • Name:
    SCHULZ, Gregor
  • Address:
    Umkirch, DE

Priority

  • Number:
    176069 P
  • Date:
    6.5.2009
  • Country:
    US
  • Number:
    259430 P
  • Date:
    9.11.2009
  • Country:
    US

Classification

  • Categories:
    A61K 47/68, A61P 35/02

Upload documents